Vanguard Capital Management’s RenovoRx RNXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.6M Buy
1,668,360
+224,618
+16% +$300K ﹤0.01% 3294
2026
Q2
$1.41M Sell
1,443,742
-3,435
-0.2% -$3.12K ﹤0.01% 3518
2026
Q1
$1.46M Buy
+1,447,177
New +$1.4M ﹤0.01% 3464

Other funds holding RNXT

Vanguard Capital Management's RNXT Position: Q3 2026 in Review

Vanguard Capital Management increased its RenovoRx (RNXT) stake by 16% in Q3 2026, buying an estimated $300K and bringing the position to 1,668,360 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3294.

Vanguard Capital Management first reported a position in RNXT in Q1 2026 and has held it in 3 quarters since. 40 funds tracked by Wall St. Rank hold RNXT as of Q3 2026.

  • Vanguard Capital Management held 1,668,360 shares of RenovoRx worth $2.6M as of Q3 2026.
  • Vanguard Capital Management bought 224,618 RenovoRx shares in Q3 2026, an estimated $300K.
  • RenovoRx made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3294 holding.
  • Vanguard Capital Management first reported a position in RenovoRx in Q1 2026 and has held it in 3 quarters since.
  • 40 funds tracked by Wall St. Rank held RenovoRx as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.